{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:06:31Z","timestamp":1792807591676,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","award":["19-24"],"award-info":[{"award-number":["19-24"]}],"id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","award":["17-27"],"award-info":[{"award-number":["17-27"]}],"id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008529","name":"Chiba University","doi-asserted-by":"publisher","award":["18-24"],"award-info":[{"award-number":["18-24"]}],"id":[{"id":"10.13039\/501100008529","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.cyto.2021.155723","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T02:21:09Z","timestamp":1634610069000},"page":"155723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae\u2013induced sepsis"],"prefix":"10.1016","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6731-909X","authenticated-orcid":false,"given":"Eizo","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinobu","family":"Akamatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Ohmori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-865X","authenticated-orcid":false,"given":"Noriko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiko","family":"Ishiwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Hishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chizuru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cyto.2021.155723_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.cyto.2021.155723_b0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1097\/00005373-198309000-00002","article-title":"Multiple organ failure in polytrauma patients","volume":"23","author":"Faist","year":"1983","journal-title":"J. Trauma"},{"issue":"7","key":"10.1016\/j.cyto.2021.155723_b0015","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.cyto.2021.155723_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cyto.2004.10.010","article-title":"Sequential measurement of IL-6 blood levels in patients with systemic inflammatory response syndrome (SIRS)\/sepsis","volume":"29","author":"Oda","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155723_b0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","article-title":"Role of disseminated intravascular coagulation in severe sepsis","volume":"178","author":"Gando","year":"2019","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.cyto.2021.155723_b0030","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1172\/JCI22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.cyto.2021.155723_b0035","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1055\/s-0037-1614900","article-title":"The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation\u2013a comparison with other anticoagulants","volume":"82","author":"Mohri","year":"1999","journal-title":"Thromb. Haemost."},{"issue":"9","key":"10.1016\/j.cyto.2021.155723_b0040","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","article-title":"A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation","volume":"41","author":"Vincent","year":"2013","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2021.155723_b0045","doi-asserted-by":"crossref","unstructured":"S. Yoshihiro, M. Sakuraya, M. Hayakawa, K. Ono, A. Hirata, A. Takaba, N. Kawamura, T. Tsutsui, K. Yoshida, Y. Hashimoto, Recombinant Human Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients with Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset, Shock 2018.","DOI":"10.1097\/SHK.0000000000001148"},{"issue":"20","key":"10.1016\/j.cyto.2021.155723_b0050","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical Trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cyto.2021.155723_b0055","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1189\/jlb.0607373","article-title":"Inflammation, endothelium, and coagulation in sepsis","volume":"83","author":"Schouten","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.cyto.2021.155723_b0060","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/nm1109-1245","article-title":"Sepsis: the dark side of histones","volume":"15","author":"Chaput","year":"2009","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155723_b0065","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tcm.2007.02.002","article-title":"Endothelial glycocalyx: sweet shield of blood vessels","volume":"17","author":"VanTeeffelen","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155723_b0070","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bcp.12629","article-title":"Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases","volume":"80","author":"Becker","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0075","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/CCM.0b013e3181b4a76b","article-title":"Streptococcus pneumoniae and Pseudomonas aeruginosa pneumonia induce distinct host responses","volume":"38","author":"McConnell","year":"2010","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.cyto.2021.155723_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-125-3-199608010-00005","article-title":"The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome","volume":"125","author":"Donnelly","year":"1996","journal-title":"Ann. Int. Med."},{"issue":"9107","key":"10.1016\/j.cyto.2021.155723_b0085","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0140-6736(05)60606-X","article-title":"Anti-inflammatory cytokine profile and mortality in febrile patients","volume":"351","author":"van Dissel","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.cyto.2021.155723_b0090","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood-2008-03-142760","article-title":"Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response","volume":"112","author":"Shi","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cyto.2021.155723_b0095","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cei.12106","article-title":"Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome","volume":"173","author":"Kudo","year":"2013","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41598-019-57205-0","article-title":"Recombinant thrombomodulin prevents acute lung injury induced by renal ischemia-reperfusion injury","volume":"10","author":"Hayase","year":"2020","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.cyto.2021.155723_b0105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl. J. Med."},{"issue":"22","key":"10.1016\/j.cyto.2021.155723_b0110","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1202290","article-title":"Drotrecogin alfa (activated) in adults with septic shock","volume":"366","author":"Ranieri","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.cyto.2021.155723_b0115","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/nm0712-1000","article-title":"Trial failure prompts soul-searching for critical-care specialists","volume":"18","author":"Dolgin","year":"2012","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.cyto.2021.155723_b0120","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nm0712-1001","article-title":"After Xigris, researchers look to new targets to combat sepsis","volume":"18","author":"Williams","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0125","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0810-3","article-title":"Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis","volume":"19","author":"Yoshimura","year":"2015","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s13054-019-2587-2","article-title":"Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis","volume":"23","author":"Yamakawa","year":"2019","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0135","doi-asserted-by":"crossref","DOI":"10.1002\/ams2.659","article-title":"The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020)","volume":"8","author":"Egi","year":"2021","journal-title":"Acute Med. Surg."},{"key":"10.1016\/j.cyto.2021.155723_b0140","first-page":"1844","article-title":"Investigation into Effect of Thrombomodulin Alfa for Septic Model Rats based on Microcirculation Image Analysis","volume":"2020","author":"Kawasaki","year":"2020","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"issue":"3","key":"10.1016\/j.cyto.2021.155723_b0145","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/ajrccm.150.3.8087341","article-title":"Compartmentalized cytokine production within the human lung in unilateral pneumonia","volume":"150","author":"Dehoux","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.cyto.2021.155723_b0150","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/174.5.994","article-title":"Interleukin-10 impairs host defense in murine pneumococcal pneumonia","volume":"174","author":"van der Poll","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.cyto.2021.155723_b0155","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/ajrccm.155.2.9032201","article-title":"Passive immunization against tumor necrosis factor-alpha impairs host defense during pneumococcal pneumonia in mice","volume":"155","author":"van der Poll","year":"1997","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.cyto.2021.155723_b0160","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/514062","article-title":"Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia","volume":"176","author":"van der Poll","year":"1997","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.cyto.2021.155723_b0165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/thx.54.10.929","article-title":"Streptococcus pneumoniae","volume":"54","author":"Catterall","year":"1999","journal-title":"Thorax"},{"issue":"13","key":"10.1016\/j.cyto.2021.155723_b0170","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1084\/jem.20111354","article-title":"A genomic storm in critically injured humans","volume":"208","author":"Xiao","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2021.155723_b0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.cyto.2021.155723_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.09.042","article-title":"Protection of the endothelial glycocalyx by antithrombin in an endotoxin-induced rat model of sepsis","volume":"171","author":"Iba","year":"2018","journal-title":"Thromb. Res."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621003124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:40:00Z","timestamp":1778794800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621003124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":36,"alternative-id":["S1043466621003124"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155723","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae\u2013induced sepsis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155723"}}